{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:27:28Z","timestamp":1769052448956,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["2020-NI-017-00"],"award-info":[{"award-number":["2020-NI-017-00"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["HD18A008"],"award-info":[{"award-number":["HD18A008"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.vaccine.2024.01.064","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T15:32:11Z","timestamp":1706887931000},"page":"1283-1291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Yun-Ho","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4714-7278","authenticated-orcid":false,"given":"Yeji","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hyun","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohyun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dokeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Ju","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.01.064_b0005","series-title":"Princes and peasants: smallpox in history","author":"Hopkins","year":"1983"},{"key":"10.1016\/j.vaccine.2024.01.064_b0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1469-0691.12536","article-title":"The rediscovery of smallpox","volume":"20","author":"Th\u00e8ves","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.01.064_b0015","series-title":"Classification of Poxviruses and Brief Characterization of the Genus Orthopoxvirus. Orthopoxviruses Pathogenic for Humans","first-page":"11","author":"Marennikova","year":"2005"},{"key":"10.1016\/j.vaccine.2024.01.064_b0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000322101","article-title":"Orthopox Viruses: Infections in Humans","volume":"37","author":"Pauli","year":"2010","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.vaccine.2024.01.064_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/08998280.2005.11928026","article-title":"Smallpox and Biological Warfare: A Disease Revisited","volume":"18","author":"Riedel","year":"2005","journal-title":"Baylor University Medical Center Proceedings"},{"key":"10.1016\/j.vaccine.2024.01.064_b0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.medmal.2003.09.009","article-title":"variole et le bioterrorisme","volume":"34","author":"La","year":"2004","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.vaccine.2024.01.064_b0035","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.064_b0040","unstructured":"Ginglen JG, Doyle MQ. Immunization. StatPearls, Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"10.1016\/j.vaccine.2024.01.064_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vaccine.2021.11.007","article-title":"Searching for the origin of the smallpox vaccine: Edward Jenner and his little-known horsepox hypothesis","volume":"40","author":"Esparza","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.064_b0050","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2105\/AJPH.2010.300051","article-title":"Smallpox: The First Vaccine","volume":"101","author":"Roth","year":"2011","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2024.01.064_b0055","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1016\/j.vaccine.2020.09.037","article-title":"Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel","volume":"38","author":"Faix","year":"2020","journal-title":"Vaccine"},{"issue":"106","key":"10.1016\/j.vaccine.2024.01.064_b0060","article-title":"The current and future landscape of smallpox vaccines","volume":"1","author":"Lane","year":"2019","journal-title":"Global Biosecurity"},{"key":"10.1016\/j.vaccine.2024.01.064_b0065","unstructured":"CJ Corporation. Inve\u2019tigator\u2019s Brochure for CJ-50300 2006."},{"key":"10.1016\/j.vaccine.2024.01.064_b0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.all.0000136758.66442.28","article-title":"Smallpox, vaccination and adverse reactions to smallpox vaccine","volume":"4","author":"Wollenberg","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2024.01.064_b0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000\u2122: The new smallpox vaccine for United States Strategic National Stockpile","author":"Nalca","year":"2010","journal-title":"DDDT"},{"key":"10.1016\/j.vaccine.2024.01.064_b0080","doi-asserted-by":"crossref","unstructured":"Sobh A, Bonilla FA. Vaccination in Primary Immunodeficiency Disorders. J Allergy Clin Immunol: In Practice 2016;4:1066\u201375. 10.1016\/j.jaip.2016.09.012.","DOI":"10.1016\/j.jaip.2016.09.012"},{"key":"10.1016\/j.vaccine.2024.01.064_b0085","doi-asserted-by":"crossref","unstructured":"Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:734\u201342. 10.15585\/mmwr.mm7122e1.","DOI":"10.15585\/mmwr.mm7122e1"},{"key":"10.1016\/j.vaccine.2024.01.064_b0090","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1016\/j.vaccine.2021.06.060","article-title":"Development of an attenuated smallpox vaccine candidate: The KVAC103 strain","volume":"39","author":"Lim","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.064_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111138","article-title":"The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses","volume":"40","author":"Jung","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2024.01.064_b0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(06)68143-9","article-title":"Smallpox","volume":"367","author":"Moore","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.01.064_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/v10030101","article-title":"Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory","volume":"10","author":"Albarnaz","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.01.064_b0110","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/MMBR.00024-15","article-title":"Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity","volume":"80","author":"VanBlargan","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2024.01.064_b0115","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1590\/0001-3765201520140663","article-title":"The re-emergency and persistence of vaccine preventable diseases","volume":"87","author":"Borba","year":"2015","journal-title":"An Acad Bras Ci\u00eanc"},{"key":"10.1016\/j.vaccine.2024.01.064_b0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.01.064_b0125","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.01.064_b0130","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.01.064_b0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.179.4.1367","article-title":"CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major","volume":"179","author":"Wang","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.01.064_b0140","first-page":"3","article-title":"Targeting 4\u20131BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens","author":"Zhao","year":"2012","journal-title":"Front Immun"},{"key":"10.1016\/j.vaccine.2024.01.064_b0145","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00040-09","article-title":"Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model","volume":"16","author":"Meseda","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.01.064_b0150","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.01.064_b0155","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","article-title":"Effect of vaccine administration modality on immunogenicity and efficacy","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.01.064_b0160","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1586\/14760584.2014.883285","article-title":"Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature","volume":"13","author":"Herzog","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.01.064_b0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-2478(98)00125-4","article-title":"Vaccinia virus immune evasion","volume":"65","author":"Smith","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2024.01.064_b0170","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"Vollmar","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.064_b0175","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE\u00ae (Modified Vaccinia Ankara) followed by Dryvax\u00ae challenge","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.064_b0180","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.1200799","article-title":"CD8 T Cells Are Essential for Recovery from a Respiratory Vaccinia Virus Infection","volume":"189","author":"Goulding","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.01.064_b0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1099\/0022-1317-1-3-399","article-title":"Respiratory Infection of Mice with Vaccinia Virus","volume":"1","author":"Turner","year":"1967","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.01.064_b0190","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1099\/0022-1317-71-11-2761","article-title":"Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route","volume":"71","author":"Williamson","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.01.064_b0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0166-3542(01)00159-0","article-title":"Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice","volume":"52","author":"Smee","year":"2001","journal-title":"Antiviral Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:33:17Z","timestamp":1759404797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0264410X24000768"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}